Human metabolic syndrome resulting from dominant-negative mutations in the nuclear receptor peroxisome proliferator-activated receptor-γ

Diabetes

Volumn 52, Issue 4, 2003, Pages 910-917

  Savage, David B ^a   Tan, Garry D ^b   Acerini, Carlo L ^a   Jebb, Susan A ^c   Agostini, Maura ^a   Gurnell, Mark ^a   Williams, Rachel L ^a   Umpleby, A Margot ^d   Thomas, E Louise ^e   Bell, Jimmy D ^e   Dixon, Adrian K ^a   Dunne, Fidelma ^f   Boiani, Romina ^g   Cinti, Saverio ^g   Vidal Puig, Antonio ^a   Karpe, Fredrik ^b   Chatterjee, V Krishna K ^a   O'Rahilly, Stephen ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b RADCLIFFE INFIRMARY   (United Kingdom)

^c Med Res Cncl Hum Nutr Research   (United Kingdom)

^d ST THOMAS HOSPITAL   (United Kingdom)

^e HAMMERSMITH HOSPITAL   (United Kingdom)

^f SELLY OAK HOSPITAL   (United Kingdom)

^g UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ACARBOSE; ADIPONECTIN; AMLODIPINE; ATENOLOL; CELL NUCLEUS RECEPTOR; CHOLESTEROL; ENALAPRIL; FATTY ACID; GLICLAZIDE; INSULIN; LEPTIN; LEUCINE; METFORMIN; NEUTRAL INSULIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROLINE; ROSIGLITAZONE; TRIACYLGLYCEROL;

ACANTHOSIS NIGRICANS; ADIPOSE TISSUE; ADULT; AMENORRHEA; ARTICLE; BODY FAT; CASE REPORT; DOMINANT GENE; FATTY LIVER; FEMALE; GENE MUTATION; HIRSUTISM; HUMAN; HUMAN CELL; HYPERINSULINEMIA; HYPERTENSION; INSULIN RESISTANCE; LIPODYSTROPHY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MALE; METABOLIC SYNDROME X; MONONUCLEAR CELL; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

ABDOMEN; ADIPOSE TISSUE; ADULT; BODY COMPOSITION; CARRIER PROTEINS; FATTY ACID-BINDING PROTEINS; FATTY ACIDS; FATTY ACIDS, NONESTERIFIED; FATTY LIVER; FEMALE; GENE EXPRESSION; HUMANS; HYPERLIPIDEMIAS; INSULIN RESISTANCE; KINETICS; LIVER; MAGNETIC RESONANCE IMAGING; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MUTATION; NEOPLASM PROTEINS; PHENOTYPE; RECEPTORS, CYTOPLASMIC AND NUCLEAR; THIAZOLES; THIAZOLIDINEDIONES; TRANSCRIPTION FACTORS; TRIGLYCERIDES; TUMOR SUPPRESSOR PROTEINS;

EID: 0344375097     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.52.4.910     Document Type: Article

References (47)

1. Desvergne B, Wahli W: Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr Rev 20:649-688, 1999
2. Rosen ED, Spiegelman BM: PPARgamma: a nuclear regulator of metabolism, differentiation, and cell growth. J Biol Chem 276:37731-37734, 2001
3. Kliewer SA, Sundseth SS, Jones SA, Brown PJ, Wisely GB, Koble CS, Devchand P, Wahli W, Willson TM, Lenhard JM, Lehmann JM: Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma. Proc Natl Acad Sci U S A 94:4318-4323, 1997
4. Kahn CR, Chen L, Cohen SE: Unraveling the mechanism of action of thiazolidinediones. J Clin Invest 106:1305-1307, 2000
5. Picard F, Auwerx J: PPARγ and glucose homeostasis. Annu Rev Nutr 22:167-197, 2002
6. Barroso I, Gurnell M, Crowley VE, Agostini M, Schwabe JW, Soos MA, Maslen GL, Williams TD, Lewis H, Schafer AJ, Chatterjee VK, O'Rahilly S: Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension. Nature 402:880-883, 1999
7. Fuller NJ, Jebb SA, Laskey MA, Coward WA, Elia M: Four-component model for the assessment of body composition in humans: comparison with alternative methods, and evaluation of the density and hydration of fat-free mass. Clin Sci (Colch) 82:687-693, 1992
8. Rico-Sanz J, Thomas EL, Jenkinson G, Mierisova S, Iles R, Bell JD: Diversity in levels of intracellular total creatine and triglycerides in human skeletal muscles observed by (1)H-MRS. J Appl Physiol 87:2068-2072, 1999
9. Powrie JK, Smith GD, Hennessy TR, Shojaee-Moradie F, Kelly JM, Sonksen PH, Jones RH: Incomplete suppression of hepatic glucose production in non-insulin dependent diabetes mellitus measured with [6,6-2H2] glucose enriched glucose infusion during hyperinsulinaemic euglycaemic clamps. Eur J Clin Invest 22:244-253, 1992
10. Frayn KN, Coppack SW, Humphreys SM: Subcutaneous adipose tissue metabolism studied by local catheterization. Int J Obes Relat Metab Disord 17 (Suppl. 3):S18-S22, 1993
11. Savage DB, Sewter CP, Klenk ES, Segal DG, Vidal-Puig A, Considine RV, O'Rahilly S: Resistin/Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-gamma action in humans. Diabetes 50:2199-2202, 2001
12. Lowell BB: PPARgamma: an essential regulator of adipogenesis and modulator of fat cell function. Cell 99:239-242, 1999
13. Fomon SF, Zieggler EE, Nelson SE: Body composition of reference children at age 10 years. Am J Clin Nutr 35:1169-1175, 1982
14. Friedman J: Fat in all the wrong places. Nature 415:268-269, 2002
15. Vantyghem MC, Vigouroux C, Magre J, Desbois-Mouthon C, Pattou F, Fontaine P, Lefebvre J, Capeau J: Late-onset lipoatrophic diabetes: phenotypic and genotypic familial studies and effect of treatment with metformin and lispro insulin analog. Diabetes Care 22:1374-1376, 1999
16. Martin G, Schoonjans K, Staels B, Auwerx J: PPARgamma activators improve glucose homeostasis by stimulating fatty acid uptake in the adipocytes. Atherosclerosis 137 (Suppl.):S75-S80, 1998
17. Bergman RN, Ader M: Free fatty acids and pathogenesis of type 2 diabetes mellitus. Trends Endocrinol Metab 11:351-356, 2000
18. Shulman GI: Cellular mechanisms of insulin resistance. J Clin Invest 106:171-176, 2000
19. Coppack SW, Evans RD, Fisher RM, Frayn KN, Gibbons GF, Humphreys SM, Kirk ML, Potts JL, Hockaday TD: Adipose tissue metabolism in obesity: lipase action in vivo before and after a mixed meal. Metabolism 41:264-272, 1992
20. Kahn BB, Flier JS: Obesity and insulin resistance. J Clin Invest 106:473-481, 2000
21. Miyazaki Y, Mahankali A, Matsuda M, Mahankali S, Hardies J, Cusi K, Mandarino LJ, DeFronzo RA: Effect of pioglitazone on abdominal fat distribution and insulin sensitivity in type 2 diabetic patients. J Clin Endocrinol Metab 87:2784-2791, 2002
22. Jackson SN, Howlett TA, McNally PG, O'Rahilly S, Trembath RC: Dunnigan-Kobberling syndrome: an autosomal dominant form of partial lipodystrophy. QJM 90:27-36, 1997.
23. Carr A, Samaras K, Thorisdottir A, Kaufmann GR, Chisholm DJ, Cooper DA: Diagnosis, prediction, and natural course of HIV-1 protease-inhibitorassociated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study. Lancet 353:2093-2099, 1999
24. Agarwal AK, Garg A: A novel heterozygous mutation in peroxisome proliferator-activated receptor-gamma gene in a patient with familial partial lipodystrophy. J Clin Endocrinol Metab 87:408-411, 2002
25. Magre J, Delepine M, Khallouf E, Gedde-Dahl T Jr, Van Maldergem L, Sobel E, Papp J, Meier M, Megarbane A, Bachy A, Verloes A, d'Abronzo FH, Seemanova E, Assan R, Baudic N, Bourut C, Czernichow P, Huet F, Grigorescu F, de Kerdanet M, Lacombe D, Labrune P, Lanza M, Loret H, Matsuda F, Navarro J, Nivelon-Chevalier A, Polak M, Robert JJ, Tric P, Tubiana-Rufi N, Vigouroux C, Weissenbach J, Savasta S, Maassen JA, Trygstad O, Bogalho P, Freitas P, Medina JL, Bonnicci F, Joffe BI, Loyson G, Panz VR, Raal FJ, O'Rahilly S, Stephenson T, Kahn CR, Lathrop M, Capeau J: Identification of the gene altered in Berardinelli-Seip congenital lipodystrophy on chromosome 11q13. Nat Genet 28:365-370, 2001
26. Shackleton S, Lloyd DJ, Jackson SN, Evans R, Niermeijer MF, Singh BM, Schmidt H, Brabant G, Kumar S, Durrington PN, Gregory S, O'Rahilly S, Trembath RC: LMNA, encoding lamin A/C, is mutated in partial lipodystrophy. Nat Genet 24:153-156, 2000
27. Kelly IE, Han TS, Walsh K, Lean ME: Effects of a thiazolidinedione compound on body fat and fat distribution of patients with type 2 diabetes. Diabetes Care 22:288-293, 1999
28. Arioglu E, Duncan-Morin J, Sebring N, Rother KI, Gottlieb N, Lieberman J, Herion D, Kleiner DE, Reynolds J, Premkumar A, Sumner AE, Hoofnagle J, Reitman ML, Taylor SI: Efficacy and safety of troglitazone in the treatment of lipodystrophy syndromes. Ann Intern Med 133:263-274, 2000
29. Reitman ML, Arioglu E, Gavrilova O, Taylor SI: Lipoatrophy revisited. Trends Endocrinol Metab 11:410-416, 2000
30. Petersen KF, Oral EA, Dufour S, Befroy D, Ariyan C, Yu C, Cline GW, DePaoli AM, Taylor SI, Gorden P, Shulman GI: Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy. J Clin Invest 109:1345-1350, 2002
31. Itani SI, Ruderman NB, Schmieder F, Boden G: Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IκB-α. Diabetes 51:2005-2011, 2002
32. Combs TP, Wagner JA, Berger J, Doebber T, Wang WJ, Zhang BB, Tanen M, Berg AH, O'Rahilly S, Savage DB, Chatterjee K, Weiss S, Larson PJ, Gottesdiener KM, Gertz BJ, Charron MJ, Scherer PE, Moller DE: Induction of adipocyte complement-related protein of 30 kilodaltons by PPARgamma agonists: a potential mechanism of insulin sensitization. Endocrinology 143:998-1007, 2002
33. Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, Mori Y, Ide T, Murakami K, Tsuboyama-Kasaoka N, Ezaki O, Akanuma Y, Gavrilova O, Vinson C, Reitman ML, Kagechika H, Shudo K, Yoda M, Nakano Y, Tobe K, Nagai R, Kimura S, Tomita M, Froguel P, Kadowaki T: The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 7:941-946, 2001
34. Berg AH, Combs TP, Du X, Brownlee M, Scherer PE: The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med 7:947-953, 2001
35. Maeda N, Takahashi M, Funahashi T, Kihara S, Nishizawa H, Kishida K, Nagaretani H, Matsuda M, Komuro R, Ouchi N, Kuriyama H, Hotta K, Nakamura T, Shimomura I, Matsuzawa Y: PPARγ ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes 50:2094-2099, 2001
36. Ginsberg HN: Insulin resistance and cardiovascular disease. J Clin Invest 106:453-458, 2000
37. Kadowald T: Insights into insulin resistance and type 2 diabetes from knockout mouse models. J Clin Invest 106:459-465, 2000
38. Engeli S, Negrel R, Sharma AM: Physiology and pathophysiology of the adipose tissue renin-angiotensin system. Hypertension 35:1270-1277, 2000
39. Yamauchi T, Waki H, Kamon J, Murakami K, Motojima K, Komeda K, Miki H, Kubota N, Terauchi Y, Tsuchida A, Tsuboyama-Kasaoka N, Yamauchi N, Ide T, Hori W, Kato S, Fukayama M, Akanuma Y, Ezaki O, Itai A, Nagai R, Kimura S, Tobe K, Kagechika H, Shudo K, Kadowaki T: Inhibition of RXR and PPARgamma ameliorates diet-induced obesity and type 2 diabetes. J Clin Invest 108:1001-1013, 2001
40. Miles PD, Barak Y, He W, Evans RM, Olefsky JM: Improved insulin-sensitivity in mice heterozygous for PPAR-gamma deficiency. J Clin Invest 105:287-292, 2000
41. Kubota N, Terauchi Y, Miki H, Tamemoto H, Yamauchi T, Komeda K, Satoh S, Nakano R, Ishii C, Sugiyama T, Eto K, Tsubamoto Y, Okuno A, Murakami K, Sekihara H, Hasegawa G, Naito M, Toyoshima Y, Tanaka S, Shiota K, Kitamura T, Fujita T, Ezaki O, Aizawa S, Kadowald T, et al.: PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance. Mol Cell 4:597-609, 1999
42. Masuzaki H, Paterson J, Shinyama H, Morton NM, Mullins JJ, Seckl JR, Flier JS: A transgenic model of visceral obesity and the metabolic syndrome. Science 294:2166-2170, 2001
43. Berger J, Tanen M, Elbrecht A, Hermanowski-Vosatka A, Moller DE, Wright SD, Thieringer R: Peroxisome proliferator-activated receptorgamma ligands inhibit adipocyte 11beta-hydroxysteroid dehydrogenase type 1 expression and activity. J Biol Chem 276:12629-12635, 2001
44. World Health Organization: Obesity: Preventing and Managing the Global Epidemic. Geneva, World Health Org./NUT/NCD, 1998
45. Gallagher D, Heymsfield SB, Heo M, Jebb SA, Murgatroyd PM, Sakamoto Y: Healthy percentage body fat ranges: an approach for developing guidelines based on body mass index. Am J Clin Nutr 72:694-701, 2000
46. Dixon AK: Abdominal fat assessed by computed tomography: sex difference in distribution. Clin Radiol 34:189-191, 1983
47. Black D, James WPT, Besser GM, Brock CGD, Craddock D, Garrow JS, Hockaday TDR, Lewis B, Pilkington TRE, Silverstone JT, Mann JI, Miller DS, Pyke DA, Williams DE, Skinner RK: Obesity: a report of the College of Physicians. J R Coll Physicians Lond 17:5-65, 1983